BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pappula AL, Rasheed S, Mirzaei G, Petreaca RC, Bouley RA. A Genome-Wide Profiling of Glioma Patients with an IDH1 Mutation Using the Catalogue of Somatic Mutations in Cancer Database. Cancers (Basel) 2021;13:4299. [PMID: 34503108 DOI: 10.3390/cancers13174299] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Qin YQ, Liu SY, Lv ML, Sun WL. Ambra1 in cancer: implications for clinical oncology. Apoptosis 2022. [PMID: 35994214 DOI: 10.1007/s10495-022-01762-9] [Reference Citation Analysis]
2 Cabezas-Camarero S, García-Barberán V, Pérez-Alfayate R, Casado-Fariñas I, Sloane H, Jones FS, Pérez-Segura P. Detection of IDH1 Mutations in Plasma Using BEAMing Technology in Patients with Gliomas. Cancers (Basel) 2022;14:2891. [PMID: 35740557 DOI: 10.3390/cancers14122891] [Reference Citation Analysis]
3 Rocha SM, Socorro S, Passarinha LA, Maia CJ. Comprehensive Landscape of STEAP Family Members Expression in Human Cancers: Unraveling the Potential Usefulness in Clinical Practice Using Integrated Bioinformatics Analysis. Data 2022;7:64. [DOI: 10.3390/data7050064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Everix L, Nair S, Driver CHS, Goethals I, Sathekge MM, Ebenhan T, Vandevoorde C, Bolcaen J. Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of Glioblastoma. Cancers (Basel) 2022;14:1821. [PMID: 35406593 DOI: 10.3390/cancers14071821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chung C, Cho HJ, Lee C, Koo J. Odorant receptors in cancer. BMB Rep 2022;55:72-80. [DOI: 10.5483/bmbrep.2022.55.2.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Liu H, Li W, An Y, Wu T, Jiang G, Dong Y, Chen W, Wang J, Wang C, Song S. Integrated analysis of the genomic and transcriptional profile of gliomas with isocitrate dehydrogenase-1 and tumor protein 53 mutations. Int J Immunopathol Pharmacol 2022;36:039463202211392. [DOI: 10.1177/03946320221139262] [Reference Citation Analysis]
7 Mirzaei G, Petreaca RC. Distribution of copy number variations and rearrangement endpoints in human cancers with a review of literature. Mutat Res 2022;824:111773. [PMID: 35091282 DOI: 10.1016/j.mrfmmm.2021.111773] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 Cho HJ, Koo J. Odorant G protein-coupled receptors as potential therapeutic targets for adult diffuse gliomas: a systematic analysis and review. BMB Rep 2021;54:601-7. [DOI: 10.5483/bmbrep.2021.54.12.165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Nelakurti DD, Rossetti T, Husbands AY, Petreaca RC. Arginine Depletion in Human Cancers. Cancers (Basel) 2021;13:6274. [PMID: 34944895 DOI: 10.3390/cancers13246274] [Reference Citation Analysis]